Withdrawal of Serious Shortage Protocol for fluoxetine 10mg capsule (England)
The Department of Health and Social Care (DHSC) has issued information about the withdrawal of Serious Shortage Protocol (SSP) for fluoxetine 10mg. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 25, 2019 Category: Drugs & Pharmacology Source Type: news
Effect of Fluoxetine on Repetitive Behaviors in ASD Youth Unclear
WEDNESDAY, Oct. 23, 2019 -- Treatment with fluoxetine results in significantly lower scores for obsessive compulsive behaviors at 16 weeks among children and adolescents with autism spectrum disorder (ASD), according to a study published in the Oct.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 23, 2019 Category: Pharmaceuticals Source Type: news
Antidepressant Prozac Doesn't Ease Obsessive Behaviors of Autism
TUESDAY, Oct. 22, 2019 -- The commonly used antidepressant Prozac doesn ' t appear to help reduce obsessive-compulsive behavior in children and teens with autism, new research suggests.
The study randomly compared use of the drug to a placebo over 16... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 22, 2019 Category: General Medicine Source Type: news
Lexapro vs. Prozac
Title: Lexapro vs. ProzacCategory: MedicationsCreated: 10/21/2019 12:00:00 AMLast Editorial Review: 10/21/2019 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - October 21, 2019 Category: Psychiatry Source Type: news
What are the effects of fluoxetine treatment in overweight or obese adults?
Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The authors identified 19 randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) evaluating mainly women receiving different doses of fluoxetine. A total of 1280 overweight or obese participants received fluoxetine and 936 p...
Source: Cochrane News and Events - October 17, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news
Featured review: What are the effects of fluoxetine treatment in overweight or obese adults?
Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The authors identified 19 randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) evaluating mainly women receiving different doses of fluoxetine. A total of 1280 overweight or obese participants received fluoxetine and 936 p...
Source: Cochrane News and Events - October 17, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news
Serious shortage protocols (SSPs) for Fluoxetine (England)
The Department of Health and Social Care has agreed the October serious shortage protocols for the following items... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 3, 2019 Category: Drugs & Pharmacology Source Type: news
